Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 14740870)

1.

Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.

Boutlis CS, Hobbs MR, Marsh RL, Misukonis MA, Tkachuk AN, Lagog M, Booth J, Granger DL, Bockarie MJ, Mgone CS, Levesque MC, Weinberg JB, Anstey NM.

Am J Trop Med Hyg. 2003 Dec;69(6):569-73.

2.

A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.

Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, Mwaikambo ED, Lal AL, Granger DL, Anstey NM, Weinberg JB.

Lancet. 2002 Nov 9;360(9344):1468-75. Erratum in: Lancet. 2003 Feb 1;361(9355):438..

PMID:
12433515
3.

Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.

Oates JC, Levesque MC, Hobbs MR, Smith EG, Molano ID, Page GP, Hill BS, Weinberg JB, Cooper GS, Gilkeson GS.

J Rheumatol. 2003 Jan;30(1):60-7.

PMID:
12508391
4.

Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria.

Kun JF, Mordmüller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG.

J Infect Dis. 2001 Aug 1;184(3):330-6. Epub 2001 Jun 26.

5.

Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria.

Levesque MC, Hobbs MR, Anstey NM, Vaughn TN, Chancellor JA, Pole A, Perkins DJ, Misukonis MA, Chanock SJ, Granger DL, Weinberg JB.

J Infect Dis. 1999 Dec;180(6):1994-2002. Erratum in: J Infect Dis 2000 Jan;181(1):408.

6.

(CCTTT)n repeat polymorphism in the NOS2 gene promoter is associated with atopy.

Konno S, Hizawa N, Yamaguchi E, Jinushi E, Nishimura M.

J Allergy Clin Immunol. 2001 Nov;108(5):810-4.

PMID:
11692109
7.

iNOS promoter variants and severe malaria in Ghanaian children.

Cramer JP, Mockenhaupt FP, Ehrhardt S, Burkhardt J, Otchwemah RN, Dietz E, Gellert S, Bienzle U.

Trop Med Int Health. 2004 Oct;9(10):1074-80.

8.
9.

Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand.

Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Looareesuwan S, Tokunaga K.

J Infect Dis. 2002 Aug 15;186(4):578-81. Epub 2002 Jul 26.

10.

Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.

Levesque MC, Hobbs MR, O'Loughlin CW, Chancellor JA, Chen Y, Tkachuk AN, Booth J, Patch KB, Allgood S, Pole AR, Fernandez CA, Mwaikambo ED, Mutabingwa TK, Fried M, Sorensen B, Duffy PE, Granger DL, Anstey NM, Weinberg JB.

Hum Genet. 2010 Feb;127(2):163-82. doi: 10.1007/s00439-009-0753-3. Epub 2009 Oct 27.

11.

Age-dependent effect of plasma nitric oxide on parasite density in Ghanaian children with severe malaria.

Cramer JP, Nüssler AK, Ehrhardt S, Burkhardt J, Otchwemah RN, Zanger P, Dietz E, Gellert S, Bienzle U, Mockenhaupt FP.

Trop Med Int Health. 2005 Jul;10(7):672-80.

12.

The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus.

López-Nevot MA, Ramal L, Jiménez-Alonso J, Martín J.

Rheumatology (Oxford). 2003 Jan;42(1):113-6.

13.

No evidence for association of the inducible nitric oxide synthase promoter polymorphism with Trypanosoma cruzi infection.

Calzada JE, López-Nevot MA, Beraún Y, Martín J.

Tissue Antigens. 2002 Apr;59(4):316-9.

PMID:
12135432
14.

Nitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphism.

Planche T, Macallan DC, Sobande T, Borrmann S, Kun JF, Krishna S, Kremsner PG.

Am J Physiol Regul Integr Comp Physiol. 2010 Nov;299(5):R1248-53. doi: 10.1152/ajpregu.00390.2010. Epub 2010 Sep 1.

15.

Inducible nitric oxide synthase promoter polymorphism in human brucellosis.

Orozco G, Sánchez E, López-Nevot MA, Caballero A, Bravo MJ, Morata P, de Dios Colmenero J, Alonso A, Martín J.

Microbes Infect. 2003 Nov;5(13):1165-9.

PMID:
14623011
16.

Plasma interleukin-12 in malaria-tolerant papua new guineans: inverse correlation with Plasmodium falciparum parasitemia and peripheral blood mononuclear cell nitric oxide synthase activity.

Boutlis CS, Lagog M, Chaisavaneeyakorn S, Misukonis MA, Bockarie MJ, Mgone CS, Wang Z, Morahan G, Weinberg JB, Udhayakumar V, Anstey NM.

Infect Immun. 2003 Nov;71(11):6354-7.

17.

NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.

Kawaguchi Y, Tochimoto A, Hara M, Kawamoto M, Sugiura T, Katsumata Y, Okada J, Kondo H, Okubo M, Kamatani N.

Arthritis Res Ther. 2006;8(4):R104.

18.

Genetic determinants of rheumatoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism.

Pascual M, López-Nevot MA, Cáliz R, Koeleman BP, Balsa A, Pascual-Salcedo D, Martín J.

Genes Immun. 2002 Aug;3(5):299-301.

19.

Nitric oxide synthase 2 (NOS2) promoter polymorphisms in colorectal cancer.

Fransén K, Elander N, Söderkvist P.

Cancer Lett. 2005 Jul 8;225(1):99-103.

PMID:
15922861
20.

Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration.

Leung TF, Liu EK, Li CY, Chan IH, Yung E, Lam CW, Wong GW.

Pediatr Pulmonol. 2006 Jul;41(7):649-55.

PMID:
16703578
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk